Re: "The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam".
Friedman
S R
SR
Des Jarlais
D C
DC
D015331:Cohort Studies; D006679:HIV Seropositivity / Q000453:epidemiology*; D006801:Humans; D016015:Logistic Models; D008691:Methadone / Q000627:therapeutic use; D016485:Needle Sharing; D009426:Netherlands; D011314:Preventive Health Services; D012044:Regression Analysis; D012309:Risk-Taking; D015819:Substance Abuse, Intravenous / Q000523:psychology*; D013594:Syringes
D008691:Methadone